Global Healthcare Analytical Testing Services Market Set for a Positive Growth Forecast at CAGR of 11.7% till 2023
Bharat Book Bureau Provides the Trending Market Research Report on “Global Healthcare Analytical Testing Services Market, Forecast to 2023” under Life Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Prominent Players, global presence, and their future prospects.
Global Healthcare Analytical Testing Services Market projected to grow at a CAGR of 11.7%
The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.
Request a free sample copy of Healthcare Analytical Testing Services Market Report @ https://www.bharatbook.com/request-sample/762886
The batch-release testing segment is expected to register the highest CAGR during the forecast period
On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, raw material testing, stability testing, batch release testing, microbial testing, and environmental monitoring. The batch-release testing segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the stringent regulations that require batch-release testing to be conducted for products marketed. In addition, the growing generic pharmaceuticals industry is further expected to drive the growth of this market.
Pharmaceutical & biopharmaceutical companies segment expected to grow at the highest CAGR during 2018 to 2023
Based on end user, the healthcare analytical testing services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies and contract research organizations. The pharmaceutical & biopharmaceutical companies segment is the fastest-growing end-user segment in the healthcare analytical testing services market during the forecast period. The growing pressure on drug manufacturers to deliver high-quality products and increasing outsourcing of analytical testing services are the major factors driving the growth of the healthcare analytical testing services market for pharmaceutical & biopharmaceutical companies.
APAC is projected to witness the highest growth during the forecast period
North America held the largest share of the global healthcare analytical testing services market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing R&D funding, growing number of CROs, and favorable government initiatives to promote pharmaceutical and biopharmaceutical industries in several APAC countries.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–28%, Tier 2–43% and Tier 3–29%
- By Designation – C-level–14%, Director Level–43%, Others–43%
- By Region – North America–43%, Europe–14%, Asia Pacific–29%, Rest of World–14%
The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), Wuxi PharmaTech (China), and BioReliance (US).
To browse full research report with TOC, click the link below :
https://www.bharatbook.com/medical-devices-market-research-reports-762886/healthcare-analytical-testing-services-type-end-user-global-forecast.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Global Healthcare Analytical Testing Services Market projected to grow at a CAGR of 11.7%
The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.
Request a free sample copy of Healthcare Analytical Testing Services Market Report @ https://www.bharatbook.com/request-sample/762886
The batch-release testing segment is expected to register the highest CAGR during the forecast period
On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, raw material testing, stability testing, batch release testing, microbial testing, and environmental monitoring. The batch-release testing segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the stringent regulations that require batch-release testing to be conducted for products marketed. In addition, the growing generic pharmaceuticals industry is further expected to drive the growth of this market.
Pharmaceutical & biopharmaceutical companies segment expected to grow at the highest CAGR during 2018 to 2023
Based on end user, the healthcare analytical testing services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies and contract research organizations. The pharmaceutical & biopharmaceutical companies segment is the fastest-growing end-user segment in the healthcare analytical testing services market during the forecast period. The growing pressure on drug manufacturers to deliver high-quality products and increasing outsourcing of analytical testing services are the major factors driving the growth of the healthcare analytical testing services market for pharmaceutical & biopharmaceutical companies.
APAC is projected to witness the highest growth during the forecast period
North America held the largest share of the global healthcare analytical testing services market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing R&D funding, growing number of CROs, and favorable government initiatives to promote pharmaceutical and biopharmaceutical industries in several APAC countries.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–28%, Tier 2–43% and Tier 3–29%
- By Designation – C-level–14%, Director Level–43%, Others–43%
- By Region – North America–43%, Europe–14%, Asia Pacific–29%, Rest of World–14%
The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), Wuxi PharmaTech (China), and BioReliance (US).
To browse full research report with TOC, click the link below :
https://www.bharatbook.com/medical-devices-market-research-reports-762886/healthcare-analytical-testing-services-type-end-user-global-forecast.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Comments
Post a Comment